A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder

Clinical trial NCT01180400 · COMPLETED

Trial details

NCT number: NCT01180400
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Major Depressive Disorder Depression

Start date: 2010-09-01
Primary completion: 2011-09-01
Enrollment: 295

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.